ACE2 and infection: Because the spike-mediated syncytium formation of the Delta strain was stronger than that of other SARS-CoV-2 variants (Rajah et al., 2021), Virofree which can inhibit the binding of Delta spike and ACE2 sensitively would become a potent drug against Delta variant infection.